Challenges in glioblastoma research: focus on the tumor microenvironment
2023; Elsevier BV; Volume: 9; Issue: 8 Linguagem: Inglês
10.1016/j.trecan.2023.02.006
ISSN2405-8033
AutoresAndréas Bikfalvi, Cristine Alvès da Costa, Tony Avril, Jean‐Vianney Barnier, Luc Bauchet, Lucie Brisson, Pierre François Cartron, Hélène Castel, Éric Chevet, Hervé Chneiweiss, Anne Clavreul, Bruno Constantin, Valérie Coronas, Thomas Daubon, Monique Dontenwill, François Ducray, Natacha Entz‐Werlé, Dominique Figarella‐Branger, Isabelle Fournier, Jean‐Sébastien Frénel, Mathieu Gabut, Thierry Galli, Julie Gavard, Gilles Huberfeld, Jean‐Philippe Hugnot, Ahmed Idbaïh, Marie‐Pierre Junier, Thomas Mathivet, Philippe Meneï, David Meyronet, Céline Mirjolet, Fabrice Morin, Jean Mosser, E. Cohen-Jonathan Moyal, Véronique Rousseau, Michel Salzet, Marc Sanson, Giorgio Seano, Émeline Tabouret, Aurélie Tchoghandjian, Laurent Turchi, François M. Vallette, Somya Vats, Maïté Verreault, Thierry Virolle,
Tópico(s)Immune cells in cancer
ResumoIn this article, the 17th author’s last name was incorrectly represented. The corrected author name is Natacha Entz-Werlé. This has been corrected in the original online article. The authors apologise for this error. Challenges in glioblastoma research: focus on the tumor microenvironmentBikfalvi et al.Trends in CancerNovember 15, 2022In BriefGlioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has been recognized as an important player and therapeutic target in GBM. However, there is a need for a full and integrated understanding of the different cellular and molecular components involved in the GBM TME and their interactions for the development of more efficient therapies. In this review, we provide a comprehensive report of the GBM TME, which assembles the contributions of physicians and translational researchers working on brain tumor pathology and therapy in France. Full-Text PDF
Referência(s)